Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice

D'Uscio, Livius V; Barton, Matthias; Shaw, Sidney; Lüscher, Thomas F (2002). Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. Cardiovascular research, 53(2), pp. 487-495. Elsevier Science 10.1016/S0008-6363(01)00469-2

[img]
Preview
Text
53-2-487.pdf - Published Version
Available under License Publisher holds Copyright.

Download (268kB) | Preview

Objective: This study investigated whether endothelial dysfunction occurs in mesenteric arteries of apoE-deficient mice and determined the role of endothelin (ET)-1, which is increased in human atherosclerosis, using an orally active endothelin ETA receptor antagonist. Methods: ApoE-deficient and C57BL/6J control mice were fed for 30 weeks with normal chow or high-fat Western-type diet alone or in combination with darusentan (LU135252; 50 mg/kg/day). Vasomotor reactivity of isolated small mesenteric arteries (I.D. 200–250 μm) was studied in vitro under perfused and pressurized conditions. Results: In both mouse strains, about one fourth of the endothelium-dependent relaxant response to acetylcholine was insensitive to inhibition by l-NAME and indomethacin. In mesenteric arteries of apoE-deficient mice on Western-type diet, increased intima-media thickness and levels of endothelin-1 protein were observed. In addition, NO-mediated endothelium-dependent relaxation to acetylcholine was reduced without affecting l-NAME/indomethacin insensitive relaxation and contractions to endothelin-1 and serotonin were enhanced. Treatment with darusentan normalized vascular structure, NO-mediated relaxation to acetylcholine and contractions to endothelin-1 and serotonin without affecting blood pressure or plasma cholesterol levels. Conclusions: Severe hypercholesterolemia in apoE-deficient mice is associated with attenuation of NO-mediated relaxation to acetylcholine and increased vascular endothelin-1 content. Chronic ETA receptor blockade may provide a new therapeutic approach to improve NO-mediated endothelium-dependent vasomotion in small arteries.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Shaw, Sidney

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0008-6363

Publisher:

Elsevier Science

Language:

English

Submitter:

Marceline Brodmann

Date Deposited:

01 Oct 2020 14:19

Last Modified:

11 Mar 2021 07:42

Publisher DOI:

10.1016/S0008-6363(01)00469-2

BORIS DOI:

10.7892/boris.115998

URI:

https://boris.unibe.ch/id/eprint/115998

Actions (login required)

Edit item Edit item
Provide Feedback